ABSI
Price
$3.02
Change
-$0.03 (-0.98%)
Updated
Jan 16 closing price
Capitalization
454.12M
65 days until earnings call
Intraday BUY SELL Signals
CRSP
Price
$53.51
Change
-$0.70 (-1.29%)
Updated
Jan 16 closing price
Capitalization
5.1B
30 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABSI vs CRSP

Header iconABSI vs CRSP Comparison
Open Charts ABSI vs CRSPBanner chart's image
Absci
Price$3.02
Change-$0.03 (-0.98%)
Volume$2.73M
Capitalization454.12M
CRISPR Therapeutics AG
Price$53.51
Change-$0.70 (-1.29%)
Volume$1.41M
Capitalization5.1B
ABSI vs CRSP Comparison Chart in %
View a ticker or compare two or three
VS
ABSI vs. CRSP commentary
Jan 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a Hold and CRSP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 18, 2026
Stock price -- (ABSI: $3.02 vs. CRSP: $53.51)
Brand notoriety: ABSI and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 64% vs. CRSP: 72%
Market capitalization -- ABSI: $454.12M vs. CRSP: $5.1B
ABSI [@Biotechnology] is valued at $454.12M. CRSP’s [@Biotechnology] market capitalization is $5.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $111.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, ABSI is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 4 TA indicator(s) are bullish while CRSP’s TA Score has 4 bullish TA indicator(s).

  • ABSI’s TA Score: 4 bullish, 5 bearish.
  • CRSP’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CRSP is a better buy in the short-term than ABSI.

Price Growth

ABSI (@Biotechnology) experienced а -9.45% price change this week, while CRSP (@Biotechnology) price change was -0.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was +4.14%, and the average quarterly price growth was +42.40%.

Reported Earning Dates

ABSI is expected to report earnings on Mar 24, 2026.

CRSP is expected to report earnings on Feb 17, 2026.

Industries' Descriptions

@Biotechnology (+1.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($5.1B) has a higher market cap than ABSI($454M). CRSP YTD gains are higher at: 2.040 vs. ABSI (-13.467). ABSI has higher annual earnings (EBITDA): -101.92M vs. CRSP (-555.73M). CRSP has more cash in the bank: 1.92B vs. ABSI (152M). ABSI has less debt than CRSP: ABSI (6.22M) vs CRSP (211M). CRSP has higher revenues than ABSI: CRSP (35M) vs ABSI (2.82M).
ABSICRSPABSI / CRSP
Capitalization454M5.1B9%
EBITDA-101.92M-555.73M18%
Gain YTD-13.4672.040-660%
P/E RatioN/AN/A-
Revenue2.82M35M8%
Total Cash152M1.92B8%
Total Debt6.22M211M3%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
78
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABSICRSP
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
70%
Momentum
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
82%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 12 days ago
90%
Bullish Trend 5 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
ABSI
Daily Signal:
Gain/Loss:
CRSP
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LAFGX18.260.02
+0.11%
Lord Abbett International Growth F
PSSRX23.42N/A
N/A
PGIM Jennison Financial Services R
USWGX32.42-0.01
-0.03%
Victory Sustainable World A
RREMX17.90-0.01
-0.06%
RBC Emerging Markets Equity R6
WPVIX32.12-0.14
-0.43%
Weitz Multi Cap Equity-Institutional Cl

ABSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABSI has been loosely correlated with RXRX. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if ABSI jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABSI
1D Price
Change %
ABSI100%
-0.98%
RXRX - ABSI
66%
Loosely correlated
+0.65%
CRSP - ABSI
62%
Loosely correlated
-1.29%
ABCL - ABSI
58%
Loosely correlated
-1.44%
SANA - ABSI
53%
Loosely correlated
-1.93%
DNA - ABSI
52%
Loosely correlated
-0.31%
More

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
-1.29%
BEAM - CRSP
72%
Closely correlated
-2.59%
RXRX - CRSP
68%
Closely correlated
+0.65%
ABSI - CRSP
62%
Loosely correlated
-0.98%
PRME - CRSP
60%
Loosely correlated
-0.25%
NTLA - CRSP
59%
Loosely correlated
+5.31%
More